Relmada Therapeutics, Inc. (RLMD)
4.52
+0.45
(+11.06%)
USD |
NASDAQ |
Sep 11, 16:00
4.62
+0.10
(+2.21%)
After-Hours: 20:00
Relmada Therapeutics Price : 4.52 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 4.60 | 4.65 | 4.295 | 4.52 | 2.629M |
| Sep 10, 2026 | 4.25 | 4.25 | 4.00 | 4.07 | 2.809M |
| Sep 09, 2026 | 4.24 | 4.28 | 4.09 | 4.09 | 1.590M |
| Sep 08, 2026 | 4.40 | 4.425 | 4.13 | 4.25 | 1.698M |
| Sep 04, 2026 | 4.35 | 4.44 | 4.32 | 4.43 | 675556.0 |
| Sep 03, 2026 | 4.55 | 4.58 | 4.33 | 4.37 | 847511.0 |
| Sep 02, 2026 | 4.54 | 4.593 | 4.365 | 4.54 | 1.417M |
| Sep 01, 2026 | 4.31 | 4.51 | 4.31 | 4.46 | 944057.0 |
| Aug 31, 2026 | 4.31 | 4.395 | 4.285 | 4.36 | 628243.0 |
| Aug 28, 2026 | 4.51 | 4.53 | 4.32 | 4.33 | 678359.0 |
| Aug 27, 2026 | 4.53 | 4.58 | 4.485 | 4.52 | 496495.0 |
| Aug 26, 2026 | 4.57 | 4.60 | 4.46 | 4.55 | 476694.0 |
| Aug 25, 2026 | 4.63 | 4.725 | 4.57 | 4.59 | 1.025M |
| Aug 24, 2026 | 4.64 | 4.64 | 4.375 | 4.58 | 935748.0 |
| Aug 21, 2026 | 4.68 | 4.76 | 4.54 | 4.63 | 985172.0 |
| Aug 20, 2026 | 4.74 | 4.79 | 4.55 | 4.64 | 1.034M |
| Aug 19, 2026 | 4.94 | 4.98 | 4.79 | 4.83 | 595935.0 |
| Aug 18, 2026 | 4.75 | 4.86 | 4.71 | 4.85 | 751699.0 |
| Aug 17, 2026 | 4.75 | 4.84 | 4.70 | 4.77 | 955951.0 |
| Aug 14, 2026 | 4.74 | 4.835 | 4.68 | 4.80 | 925432.0 |
| Aug 13, 2026 | 4.74 | 4.89 | 4.655 | 4.75 | 1.250M |
| Aug 12, 2026 | 4.52 | 4.81 | 4.51 | 4.72 | 1.663M |
| Aug 11, 2026 | 4.55 | 4.63 | 4.35 | 4.47 | 2.141M |
| Aug 10, 2026 | 4.91 | 4.935 | 4.505 | 4.54 | 1.806M |
| Aug 07, 2026 | 5.445 | 5.55 | 4.87 | 4.94 | 2.125M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ANI Pharmaceuticals, Inc. | 70.19 |
| Corcept Therapeutics, Inc. | 112.79 |
| Veru, Inc. | 2.44 |
| Johnson & Johnson | 265.58 |
| Eli Lilly & Co. | 1115.70 |
Price Related Metrics
| Price to Book Value | 2.334 |
| Earnings Yield | -20.58% |
| Market Cap | 482.15M |